THE NETWORK OF FUNCTIONAL AND METABOLIC DISORDERS IN CHILDREN WITH DIABETIC NEPHROPATHY

Authors

DOI:

https://doi.org/10.30890/2709-2313.2023-24-03-011

Keywords:

diabetes mellitus, diabetic nephropathy, stage progression, ET-1, GFR, metabolic disorders, lipids oxidation

Abstract

Type 1 diabetes (T1D) is mainly a disease of children and young adults. One of the complications developed as a result of microangiopathy is diabetic nephropathy (DN). Lastly, we concentrate on the fact that DN is distinguished by an extended clinically s

Metrics

Metrics Loading ...

References

Sifuentes-Franco S. et al. “Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy.” International journal of endocrinology. April. – 2018.

KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease Am J Kidney Dis. – 2007. – 49 (2 suppl 2): 12–154.

Lithovius R, Mutter S, Parente EB, Mäkinen VP, Valo E, Harjutsalo V, Groop PH. Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups. Sci Rep. 2023;13(1):17893.

National Institute of Diabetes and Digestive and Kidney Diseases. Diabetic kidney disease. November.-2017. https://www.niddk.nih.gov/health-iformation/diabetes/overview/preventing-problems/diabetic-kidney-disease.

Benigni A, Buelli S, Kohan DE. Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition. Pediatr Nephrol. 2021; 36(4): 763-775.

Burlaka I, Maidannyk V. Early functional and metabolic disorders in children with type I diabetes mellitus and diabetic nephropathy. Pediatr Endocrinol Diabetes Metab. 2021;27(3):170-177.

Chaudhari S, Pham GS, Brooks CD, Dinh VQ, Young-Stubbs CM, Shimoura CG, Mathis KW. Should Renal Inflammation Be Targeted While Treating Hypertension? Front Physiol. 2022;13:886779

Babatunde HE, Bello AO, Adeboye MAN, Folayan OS, Ojewole OE, Abubakar U. Cystatin C-derived estimated glomerular filtration rate in children with sickle cell anaemia. BMC Nephrol. 2023;24(1):349.

Demirel F., Tepe D., Kara O., Esen I. Microvascular complications in adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. – 2013. - 5(3):145‐149.

American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. – 2015. - 33 (2):97-111.

Collins A.J., Foley R.N., Chavers B. et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. – 2012. – 59 (1 Suppl 1): A7, e1–420.

Marshall S.M. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? Diabetologia. – 2012. - 55(9): 2301–2306.

Elendu C, John Okah M, Fiemotongha KDJ, Adeyemo BI, Bassey BN, Omeludike EK, Obidigbo B. Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review. Medicine (Baltimore). 2023;102(40): 35397

Maahs D.M., Jalal D., Chonchol M. et al. Impaired Renal Function Further Increases Odds of 6-Year Coronary Artery Calcification Progression in Adults With Type 1 Diabetes: The CACTI study. Diabetes Care. – 2013. - 36(9): 2607–2614.

Daniels M., DuBose S.N., Maahs D.M. et al. Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. Diabetes Care. – 2013. - 36(9): 2639–2645.

Johnson MJ, Tommerdahl KL, Vinovskis C, Waikar S, Reinicke T, Parikh CR, Obeid W, Nelson RG, van Raalte DH, Pyle L, Nadeau KJ, Bjornstad P. Relationship between biomarkers of tubular injury and intrarenal hemodynamic dysfunction in youth with type 1 diabetes. Pediatr Nephrol. 2022; 37(12):3085-3092

Wood J.R., Miller K.M., Maahs D.M. et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes care. – 2013. - 36(7): 2035–2037.

Muhari-Stark E., Burckart G.J. Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal Use. J Pediatr Pharmacol Ther. – 2018. - 23(6):424‐431.

de Boer I.H., Bangalore S., Benetos A. et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care. 2017. - 40 (9):1273-1284.

Vupputuri S., Batuman V., Muntner P. et al. Effect of blood pressure on early decline in kidney function among hypertensive men. Hypertension. – 2003. - 42(6):1144‐1149.

Eriksen B.O., Stefansson V.T., Jenssen T.G. et al. Blood pressure and age-related GFR decline in the general population. BMC Nephrol. – 2017. - 18(1):77.

Burlaka Ie. Beyond Proteinuria: Apoptosis and Vitamin D3 State in Children with Diabetic Nephropathy. J Clin Exp Pathol. – 2016. - 6: 266.

Maidannyk V., Burlaka Ie. Association of Vitamin D deficiency, cellular hypoxia, and caspase-3 with renal disease in pediatric diabetic nephropathy. Journal of Translational Science. – 2016 . -2(2): 130-133.

De Miguel C., Speed J.S., Kasztan M. et al. Endothelin-1 and the kidney: new perspectives and recent findings. Curr Opin Nephrol Hypertens. – 2016. - 25(1): 35-41.

Manucha W., Juncos L.I. The protective role of vitamin D on the heart and the kidney. Ther Adv Cardiovasc Dis. – 2017. - 11(1):12‐19.

Chiang J. Hypertension and Diabetic Kidney Disease in Children and Adolescents. Diabetes Spectr. – 2015. - 28(3): 220‐224.

Steinke J.M., Mauer M. International Diabetic Nephropathy Study Group. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev. – 2008. - 5(Suppl. 4): 958–963.

Schults C.J., Konopelska-Bahu T., Dalton R.N. et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care. – 1999. - 22: 495–502.

de Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?. Kidney Int Suppl. – 2004. - (92): 2‐6.

Bouillon R., Carmeliet G.,, Verlinden L. et al. Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice, Endocrine Reviews. – 2008 – 29 (6): 726–776.

Published

2023-11-30

How to Cite

Burlaka, I. (2023). THE NETWORK OF FUNCTIONAL AND METABOLIC DISORDERS IN CHILDREN WITH DIABETIC NEPHROPATHY. European Science, 3(sge24-03), 50–59. https://doi.org/10.30890/2709-2313.2023-24-03-011